Patents by Inventor Luz Romero Alonso
Luz Romero Alonso has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Patent number: 8188115Abstract: The invention relates to compounds having pharmacological activity towards the 5-HT7 receptor, and more particularly to some tetrahydroisoquinoline substituted sulfonamide compounds, to processes of preparation of such compounds, to pharmaceutical compositions comprising them, and to their use for the treatment and or prophylaxis of a disease in which 5-HT is involved, such as CNS disorders.Type: GrantFiled: August 18, 2005Date of Patent: May 29, 2012Assignee: Laboratorios Del Dr. Esteve, S.A.Inventors: Antoni Torrens Jover, Josep Mas Prio, Susana Yenes Minguez, Mónica Garcia Lopez, Alberto Dordal Zueras, Luz Romero Alonso, Helmut Henrich Buschmann
-
Patent number: 8148397Abstract: The invention relates to compounds having pharmacological activity towards the 5-HT7 receptor, and more particularly to some tetrahydroisoquinoline propyl sulfonamide compounds, to processes of preparation of such compounds, to pharmaceutical compositions comprising them, and to their use for the treatment and or prophylaxis of a disease in which 5-HT is involved, such as CNS disorders.Type: GrantFiled: August 18, 2005Date of Patent: April 3, 2012Assignee: Laboratorios Del Dr. Esteve, S.A.Inventors: Antoni Torrens Jover, Josep Mas Prio, Susana Yenes Minguez, Monica Garcia Lopez, Alberto Dordal Zueras, Luz Romero Alonso, Helmut Henrich Buschmann
-
Patent number: 7928121Abstract: The invention relates to compounds having pharmacological activity towards the 5-HT7 receptor, and more particularly to some tetrahydroisoquinoline substituted sulfonamide compounds, to processes of preparation of such compounds, to pharmaceutical compositions comprising them, and to their use for the treatment and or prophylaxis of a disease in which 5-HT is involved, such as CNS disorders.Type: GrantFiled: December 27, 2005Date of Patent: April 19, 2011Assignee: Laboratorios Del Dr. Esteve, S.A.Inventors: Antoni Torrens Jover, Susana Yenes Mínguez, Josep Mas Prió, Luz Romero Alonso, Alberto Dordal Zueras, Helmut Henrich Buschmann
-
Publication number: 20100197717Abstract: The present invention refers to a combination of a 5HT7 receptor ligand and an opioid receptor ligand, especially of a 5HT7 receptor agonist and an opioid receptor agonist, a medicament comprising this combination, or the use of this combination for the treatment of the symptoms of pain, the prevention or the prophylaxis of the symptoms of pain.Type: ApplicationFiled: May 27, 2008Publication date: August 5, 2010Inventors: Luz Romero-Alonso, Daniel Zamanillo-Castanedo, José-Miguel Vela-Hernandez, Helmut H. Buschmann
-
Publication number: 20100152252Abstract: The present invention relates to heterocyclyl-substituted-ethylamino-phenyl compounds of general formula (I), wherein K-L-M-N, Z and R1, R2, R3, R4 are as described in the claims methods for their preparation, medicaments comprising these compounds as well as their use for the preparation of a medicament for the treatment of humans or animals.Type: ApplicationFiled: December 21, 2007Publication date: June 17, 2010Applicant: LABORATORIOS DEL DR. ESTEVE,S.A.Inventors: Mónica Garcia-López, Antonio Torrens-Jover, Luz Romero-Alonso, Helmut H. Buschmann
-
Patent number: 7662862Abstract: The invention relates to compounds having pharmacological activity towards the 5-HT7 receptor, and more particularly to some 2,2a,4,5-tetrahydro-1H-3-aza-acenaphthylen substituted sulfonamide compounds, to processes of preparation of such compounds, to pharmaceutical compositions comprising them, and to their use for the treatment and or prophylaxis of a disease in which 5-HT is involved, such as CNS disorders.Type: GrantFiled: May 22, 2009Date of Patent: February 16, 2010Assignee: Laboratorios Del Dr. Esteve, S.A.Inventors: Antoni Torrens Jover, Susana Yenes Mínguez, Josep Mas Prió, Luz Romero Alonso, Alberto Dordal Zueras, Helmut Henrich Buschmann
-
Publication number: 20090326014Abstract: The present invention refers to the use of 5-HT7 receptor agonists for the treatment of pain and the symptoms of pain, especially certain subtypes of pain like neuropathic pain and inflammatory pain and symptoms involving allodynia and hyperalgesia, the prevention or the prophylaxis of pain and the symptoms of pain, especially certain subtypes of pain like neuropathic pain and inflammatory pain and symptoms involving allodynia and hyperalgesia.Type: ApplicationFiled: June 29, 2007Publication date: December 31, 2009Applicant: Laboratorios Del Dr. Esteve, S.A.Inventors: Jose Miguel Vela Hernandez, Antonio Torrens-Jover, Helmut H. Buschmann, Luz Romero-Alonso
-
Publication number: 20090264458Abstract: The invention relates to compounds having pharmacological activity towards the 5-receptor, and more particularly to some 2,2a,4,5-tetrahydro-1H-3-aza-acenaphthylen substituted sulfonamide compounds, to processes of preparation of such compounds, to pharmaceutical compositions comprising them, and to their use for the treatment and or prophylaxis of a disease in which 5-HT is involved, such as CNS disorders.Type: ApplicationFiled: May 22, 2009Publication date: October 22, 2009Inventors: Antoni Torrens Jover, Susana Yenes Minguez, Josep Mas Prio, Luz Romero Alonso, Alberto Dordal Zueras, Helmut Henrich Buschmann
-
Patent number: 7553965Abstract: The invention relates to compounds having pharmacological activity towards the 5-HT7 receptor, and more particularly to some 2,2a,4,5-tetrahydro-1H-3-aza-acenaphthylen substituted sulfonamide compounds, to processes of preparation of such compounds, to pharmaceutical compositions comprising them, and to their use for the treatment and or prophylaxis of a disease in which 5-HT is involved, such as CNS disorders.Type: GrantFiled: December 27, 2005Date of Patent: June 30, 2009Assignee: Laboratories Del Dr. Esteve, S.A.Inventors: Antoni Torrens Jover, Susana Yenes Mínguez, Josep Mas Prió, Luz Romero Alonso, Alberto Dordal Zueras, Helmut Henrich Buschmann
-
Publication number: 20090163542Abstract: The invention relates to compounds having pharmacological activity towards the 5-HT7 receptor, and more particularly to some tetrahydroisoquinoline substituted sulfonamide compounds, to processes of preparation of such compounds, to pharmaceutical compositions comprising them, and to their use for the treatment and or prophylaxis of a disease in which 5-HT is involved, such as CNS disorders.Type: ApplicationFiled: August 18, 2005Publication date: June 25, 2009Inventors: Antoni Torrens Jover, Josep Mas Prio, Susana Yenes Minguez, Monica Garcia Lopez, Alberto Dordal Zueras, Luz Romero Alonso, Helmut Henrich Buschmann
-
Publication number: 20090036480Abstract: The invention relates to compounds having pharmacological activity towards the 5-HT7 receptor, and more particularly to some 2,2a,4,5-tetrahydro-1H-3-aza-acenaphthylen substituted sulfonamide compounds, to processes of preparation of such compounds, to pharmaceutical compositions comprising them, and to their use for the treatment and or prophylaxis of a disease in which 5-HT is involved, such as CNS disorders.Type: ApplicationFiled: December 27, 2005Publication date: February 5, 2009Inventors: Antoni Torrens Jover, Susana Yenes Minguez, Josep Mas Prio, Luz Romero Alonso, Alberto Dordal Zueras, Helmut Henrich Buschmann
-
Publication number: 20080214603Abstract: The invention relates to compounds having pharmacological activity towards the 5-HT7 receptor, and more particularly to some tetrahydroisoquinoline substituted sulfonamide compounds, to processes of preparation of such compounds, to pharmaceutical compositions comprising them, and to their use for the treatment and or prophylaxis of a disease in which 5-HT is involved, such as CNS disorders.Type: ApplicationFiled: December 27, 2005Publication date: September 4, 2008Inventors: Antoni Torrens Jover, Susana Yenes Minguez, Josep Mas Prio, Luz Romero Alonso, Alberto Dordal Zueras, Helmut Henrich Buschmann
-
Patent number: 7345057Abstract: The invention relates to compounds having pharmacological activity towards the 5-HT7 receptor, and more particularly to some some tetrahydroisoquinoline substituted sulfonamide compounds, to processes of preparation of such compounds, to pharmaceutical compositions comprising them, and to their use for the treatment and or prophylaxis of a disease in which 5-HT is involved, such as CNS disorders.Type: GrantFiled: February 2, 2005Date of Patent: March 18, 2008Assignee: Laboratorios Del Dr. Esteve, S.A.Inventors: Antoni Torrens Jover, Susana Yenes Minguez, Jose Mas Prio, Luz Romero Alonso, Alberto Dordal Zueras, Helmut H. Buschmann
-
Patent number: 7211585Abstract: The invention relates to compounds having pharmacological activity towards the 5-HT7 receptor, and more particularly to some tetrahydroisoquinoline substituted sulfonamide compounds, to processes of preparation of such compounds, to pharmaceutical compositions comprising them, and to their use for the treatment and or prophylaxis of a disease in which 5-HT is involved, such as CNS disorders.Type: GrantFiled: August 18, 2004Date of Patent: May 1, 2007Assignee: Laboratorios del Dr. Esteve, S.A.Inventors: Antoni Torrens Jover, Josep Mas Prio, Susana Yenes Minguez, Monica Garcia Lopez, Alberto Dordal Zueras, Luz Romero Alonso, Helmut H. Buschmann
-
Patent number: 7211584Abstract: The invention relates to compounds having pharmacological activity towards the 5-HT7 receptor, and more particularly to some tetrahydroisoquinoline propyl sulfonamide compounds, to processes of preparation of such compounds, to pharmaceutical compositions comprising them, and to their use for the treatment and or prophylaxis of a disease in which 5-HT is involved, such as CNS disorders.Type: GrantFiled: August 18, 2004Date of Patent: May 1, 2007Assignee: Laboratorios del Dr. Esteve, S.A.Inventors: Antoni Torrens Jover, Josep Mas Prio, Susana Yenes Minguez, Monica Garcia Lopez, Alberto Dordal Zueras, Luz Romero Alonso, Helmut H. Buschmann
-
Publication number: 20060142321Abstract: The invention relates to compounds having pharmacological activity towards the 5-HT7 receptor, and more particularly to some some 2,2a,4,5-tetrahydro-1H-3-aza-acenaphthylen substituted sulfonamide compounds, to processes of preparation of such compounds, to pharmaceutical compositions comprising them, and to their use for the treatment and or prophylaxis of a disease in which 5-HT is involved, such as CNS disorders.Type: ApplicationFiled: February 2, 2005Publication date: June 29, 2006Inventors: Antoni Jover, Susana Yenes Minguez, Jose Mas Prio, Luz Romero Alonso, Alberto Dordal Zueras, Helmut Buschmann
-
Publication number: 20060142332Abstract: The invention relates to compounds having pharmacological activity towards the 5-HT7 receptor, and more particularly to some some tetrahydroisoquinoline substituted sulfonamide compounds, to processes of preparation of such compounds, to pharmaceutical compositions comprising them, and to their use for the treatment and or prophylaxis of a disease in which 5-HT is involved, such as CNS disorders.Type: ApplicationFiled: February 2, 2005Publication date: June 29, 2006Inventors: Antoni Torrens Jover, Susana Yenes Minguez, Jose Prio, Luz Romero Alonso, Alberto Dordal Zueras, Helmut Buschmann
-
Publication number: 20060040978Abstract: The invention relates to compounds having pharmacological activity towards the 5-HT7 receptor, and more particularly to some tetrahydroisoquinoline substituted sulfonamide compounds, to processes of preparation of such compounds, to pharmaceutical compositions comprising them, and to their use for the treatment and or prophylaxis of a disease in which 5-HT is involved, such as CNS disorders.Type: ApplicationFiled: August 18, 2004Publication date: February 23, 2006Inventors: Antoni Torrens Jover, Josep Mas Prio, Susana Yenes Minguez, Monica Garcia Lopez, Alberto Dordal Zueras, Luz Romero Alonso, Helmut Buschmann
-
Publication number: 20060040977Abstract: The invention relates to compounds having pharmacological activity towards the 5-HT7 receptor, and more particularly to some tetrahydroisoquinoline propyl sulfonamide compounds, to processes of preparation of such compounds, to pharmaceutical compositions comprising them, and to their use for the treatment and or prophylaxis of a disease in which 5-HT is involved, such as CNS disorders.Type: ApplicationFiled: August 18, 2004Publication date: February 23, 2006Inventors: Antoni Torrens Jover, Josep Mas Prio, Susana Yenes Minguez, Monica Garcia Lopez, Alberto Dordal Zueras, Luz Romero Alonso, Helmut Buschmann